Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 164

1.

Exercise effects in Huntington disease.

Frese S, Petersen JA, Ligon-Auer M, Mueller SM, Mihaylova V, Gehrig SM, Kana V, Rushing EJ, Unterburger E, Kägi G, Burgunder JM, Toigo M, Jung HH.

J Neurol. 2017 Jan;264(1):32-39. doi: 10.1007/s00415-016-8310-1. Epub 2016 Oct 17.

PMID:
27747393
2.

Clinical and genetic characteristics in patients with Huntington's disease from China.

Yang J, Chen K, Wei Q, Chen Y, Cao B, Burgunder JM, Shang HF.

Neurol Res. 2016 Oct;38(10):916-20. doi: 10.1080/01616412.2016.1214555. Epub 2016 Jul 29.

PMID:
27483361
3.

Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.

Jacobs M, Hart EP, van Zwet EW, Bentivoglio AR, Burgunder JM, Craufurd D, Reilmann R, Saft C, Roos RA; REGISTRY investigators of the European Huntington’s Disease Network.

J Neurol. 2016 Oct;263(10):2080-5. doi: 10.1007/s00415-016-8233-x. Epub 2016 Jul 19.

4.

Clinical manifestations of intermediate allele carriers in Huntington disease.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network.

Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8.

PMID:
27402890
5.

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities.

Esposito G, Burgunder JM, Dunlop J, Gorwood P, Inamdar A, Pfister SM, Pochet R, van den Bent MJ, Van Hoylandt N, Weller M, Westphal M, Wick W, Nutt D.

Public Health Genomics. 2016;19(3):170-7. doi: 10.1159/000446535. Epub 2016 Jun 1.

PMID:
27238144
6.

Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.

Zeng Y, Guo W, Xu G, Wang Q, Feng L, Long S, Liang F, Huang Y, Lu X, Li S, Zhou J, Burgunder JM, Pang J, Pei Z.

Drug Des Devel Ther. 2016 Apr 13;10:1443-51. doi: 10.2147/DDDT.S94666. eCollection 2016.

7.

Brain alterations with deep brain stimulation: New insight from a neuropathological case series.

Kronenbuerger M, Nolte KW, Coenen VA, Burgunder JM, Krauss JK, Weis J.

Mov Disord. 2015 Jul;30(8):1125-30. doi: 10.1002/mds.26247. Epub 2015 May 23.

PMID:
26011773
8.

Myotonia congenita-associated mutations in chloride channel-1 affect zebrafish body wave swimming kinematics.

Cheng W, Tian J, Burgunder JM, Hunziker W, Eng HL.

PLoS One. 2014 Aug 1;9(8):e103445. doi: 10.1371/journal.pone.0103445. eCollection 2014.

9.

Genetics of Huntington's disease and related disorders.

Burgunder JM.

Drug Discov Today. 2014 Jul;19(7):985-9. doi: 10.1016/j.drudis.2014.03.005. Epub 2014 Mar 18. Review.

PMID:
24657309
10.

Recent progress in the genetics of motor neuron disease.

Finsterer J, Burgunder JM.

Eur J Med Genet. 2014 Feb;57(2-3):103-12. doi: 10.1016/j.ejmg.2014.01.002. Epub 2014 Feb 4. Review.

PMID:
24503148
11.

Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls.

Jiang H, Sun YM, Hao Y, Yan YP, Chen K, Xin SH, Tang YP, Li XH, Jun T, Chen YY, Liu ZJ, Wang CR, Li H, Pei Z, Shang HF, Zhang BR, Gu WH, Wu ZY, Tang BS, Burgunder JM; Chinese HD Network.

Eur J Neurol. 2014 Apr;21(4):637-42. doi: 10.1111/ene.12366. Epub 2014 Jan 28.

PMID:
24471773
12.

EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.

van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Dürr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O.

Eur J Neurol. 2014 Apr;21(4):552-62. doi: 10.1111/ene.12341. Epub 2014 Jan 13.

PMID:
24418350
13.

The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.

Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network, Nguyen HP.

PLoS One. 2013 Jul 22;8(7):e68951. doi: 10.1371/journal.pone.0068951. Print 2013.

14.

Suicidal ideation in a European Huntington's disease population.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network.

J Affect Disord. 2013 Oct;151(1):248-58. doi: 10.1016/j.jad.2013.06.001. Epub 2013 Jul 20.

15.

Association of MTHFR C677T polymorphism with susceptibility to migraine in the Chinese population.

An XK, Lu CX, Ma QL, Zhang XR, Burgunder JM, Lin Q, Qu HL.

Neurosci Lett. 2013 Aug 9;549:78-81. doi: 10.1016/j.neulet.2013.06.028. Epub 2013 Jun 27.

PMID:
23811028
16.

EFNS review on the role of muscle biopsy in the investigation of myalgia.

Kyriakides T, Angelini C, Schaefer J, Mongini T, Siciliano G, Sacconi S, Joseph J, Burgunder JM, Bindoff LA, Vissing J, de Visser M, Hilton-Jones D.

Eur J Neurol. 2013 Jul;20(7):997-1005. doi: 10.1111/ene.12174. Epub 2013 Apr 30. Review.

PMID:
23627674
17.

PRRT2 mutation screening in patients with paroxysmal kinesigenic dyskinesia from Southwest China.

Chen YP, Song W, Yang J, Zheng ZZ, Huang R, Chen K, Zhao B, Chen XP, Burgunder JM, Shang HF.

Eur J Neurol. 2014;21(1):174-6. doi: 10.1111/ene.12122. Epub 2013 Mar 16.

PMID:
23496026
18.

Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease.

Hart EP, Marinus J, Burgunder JM, Bentivoglio AR, Craufurd D, Reilmann R, Saft C, Roos RA; REGISTRY Investigators of the European Huntington's Disease Network.

Mov Disord. 2013 Jul;28(8):1142-5. doi: 10.1002/mds.25422. Epub 2013 Mar 14.

PMID:
23495076
19.

Recent advances in the management of choreas.

Burgunder JM.

Ther Adv Neurol Disord. 2013 Mar;6(2):117-27. doi: 10.1177/1756285612471700.

20.

Translational research in Huntington's disease: opening up for disease modifying treatment.

Burgunder JM.

Transl Neurodegener. 2013 Jan 25;2(1):2. doi: 10.1186/2047-9158-2-2.

Supplemental Content

Loading ...
Support Center